
Soxocef S 250mg/125mg Injection
Marketer
Natchem Pharma
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Soxocef S 250mg/125mg Injection
Cefixime and Sulbactam injection (250mg/125mg) combats bacterial infections by inhibiting microbial growth and propagation. Administered only by a healthcare provider, this dual-action medication requires adherence to the prescribed treatment schedule. Complete the full course, even with symptom improvement, as premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; severe reactions necessitate immediate medical attention. Allergic responses (e.g., rash, itching, swelling, dyspnea) demand immediate medical help. Inform your physician of all current medications, especially if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While driving ability is typically unaffected, refrain from driving if experiencing somnolence or dizziness. Adequate rest, nutrition, and hydration promote optimal recovery. Laboratory tests may be employed to monitor therapeutic response.
Uses of Soxocef S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Soxocef S 250mg/125mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Soxocef S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Soxocef S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Soxocef S 250mg/125mg Injection works:
Ceftriaxone and Sulbactam, combined as Soxocef S 250mg/125mg Injection, offer a dual-action approach to bacterial infection. Ceftriaxone, a crucial antibiotic component, disrupts bacterial cell wall synthesis, hindering their ability to thrive. Sulbactam, a beta-lactamase inhibitor, counters bacterial resistance mechanisms, thus bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Soxocef S 250mg/125mg Injection and alcohol consumption.
PregnancySAFE IF PRESCRIBED
The injectable medication, Soxocef S 250mg/125mg, is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harmful consequences to the fetus; nevertheless, research involving human subjects is scarce.
Breast feedingCAUTION
The administration of Soxocef S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's course of treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Soxocef S 250mg/125mg Injection can cause drowsiness, visual disturbances, and dizziness. Refrain from driving if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Soxocef S 250mg/125mg Injection to individuals with renal impairment. Seek medical advice.
LiverCAUTION
For individuals with severe hepatic impairment, administering Soxocef S 250mg/125mg Injection requires careful consideration and potential dosage modification. Consult a physician before use. Dosage alteration for Soxocef S 250mg/125mg Injection is unnecessary in patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Soxocef S 250mg/125mg Injection :
Omit a Soxocef S 250mg/125mg Injection dose? Seek your physician's advice.
Facts to Know About Soxocef S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |
